Screener
Ultragenyx Pharmaceutical RARE Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Ultragenyx Pharmaceutical in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Ultragenyx Pharmaceutical’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333233
FAQ
- What is Ultragenyx Pharmaceutical's total assets?
- Ultragenyx Pharmaceutical (RARE) reported total assets of $1.26B in Q2 2026.
- How has Ultragenyx Pharmaceutical's total assets changed year-over-year?
- Ultragenyx Pharmaceutical's total assets decreased by 3.2% year-over-year, from $1.31B to $1.26B.
- What is the long-term trend for Ultragenyx Pharmaceutical's total assets?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's total assets has grown at a -2.7% compound annual growth rate (CAGR), from $1.76B to $1.53B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Ultragenyx Pharmaceutical's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude